TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

NP47825 Multiple Sclerosis Medicines

Pharmaceutical products
Published value
Not published
Submission deadline Not published
Lots published2
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS): "NP47825 Multiple Sclerosis Medicines". Published status: complete. Published value: Value not published. 2 published lots. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)Scope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS). These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
Not availableNo published reports
Bid counts are not published for this buyer
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 0 active published awards; 0 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSFramework
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published2 May 2025, 09:05 BST
Last source update2 May 2025, 09:05 BST
Recurring procurementNot published
ClassificationPharmaceutical products
Delivery area
OCIDocds-h6vhtk-04ce06
What is being bought
Supply of multiple sclerosis medicines to NHS Scotland.
What changed
From the official release history
  1. Status changed to complete
    2 May 2025, 09:05 BST
  2. Official notice release published
    2 May 2025, 09:05 BST
  3. tender value changed
    8 Jan 2025, 09:37 GMT
  4. Status changed to published status
    8 Jan 2025, 09:37 GMT
  5. Official notice release published
    8 Jan 2025, 09:37 GMT
  6. Submission deadline changed to published date
    8 Jan 2025, 09:37 GMT
  7. Published value updated to £51,517,832
    7 Jan 2025, 17:01 GMT
  8. Status changed to active
    7 Jan 2025, 17:01 GMT
  9. Official notice release published
    7 Jan 2025, 17:01 GMT
  10. Submission deadline changed to 7 Feb 2025, 12:00 GMT
    7 Jan 2025, 17:01 GMT
  11. Buyer information updated
    7 Jan 2025, 17:01 GMT
Lots and requirements (2)
Published by the contracting authority
  • Lot 1 · #1
    Glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumab
    cancelled
    Published valueNot published
    Supply of glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumab to NHS Scotland. The Authority has awarded this Lot as an unranked multi supplier Framework Agreement per line to six (6) Framework Participants. Full details of Goods and volumes can be found within the ITT (Invitation to Tender) documents.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 2 · #2
    Fingolimod capsules, teriflunomide tablets, and dimethyl fumarate capsules
    cancelled
    Published valueNot published
    Supply of fingolimod capsules, teriflunomide tablets, and dimethyl fumarate capsules to NHS Scotland. The Authority has award this Lot as a single supplier Framework Agreement per product line to three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    2 May 2025, 09:05 BST
  2. Award active
    Not published · Not published
  3. Award active
    Not published · Not published
  4. Contract active
    Signed 15 Apr 2025, 00:00 BST · £602,376
  5. Contract active
    Signed 9 Apr 2025, 00:00 BST · £47,968,904
Commercial outcome and competition
Awards
Biogen Idec Ltd, Merck Serono Limited, Orifarm UK, Sandoz Ltd, Teva UK Ltd, Viatris UK Healthcare Ltd
Not published · Not published · active
Ranbaxy (UK) Ltd, STADA UK - Thornton & Ross, Teva UK Ltd
Not published · Not published · active
Contracts
Fingolimod capsules, teriflunomide tablets, and dimethyl fumarate capsules
£602,376 · signed 15 Apr 2025, 00:00 BST · active
Glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumab
£47,968,904 · signed 9 Apr 2025, 00:00 BST · active
Bid statistics
bids: 6 (lot 1)
electronicBids: 6 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromNonEU: 6 (lot 1)
smeBids: 0 (lot 1)
bids: 10 (lot 2)
electronicBids: 10 (lot 2)
foreignBidsFromEU: 0 (lot 2)
foreignBidsFromNonEU: 10 (lot 2)
smeBids: 0 (lot 2)
Buyer and organisations in this procedure

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

Contracting authority GB-FTS-115937
View buyer profile
  • The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
    buyer
    centralPurchasingBody

    1 South Gyle Crescent, Edinburgh, UKM, EH12 9EB
    +44 870831908
  • Biogen Idec Ltd
    supplier

    Biogen Building 5 Foundation Park, , Roxborough Way, Maidenhead, Berkshire, England,, Maidenhead, UK, SL6 3UD
    +44 7860270707
  • Merck Serono Limited
    supplier

    5 New Square, Bedfont Lakes Business Park , Feltham, Middlesex, UKI75, TW14 8HA
    +44 7423735163
  • Orifarm UK
    supplier

    www.orifarm.com, 10015046, Hemel Hempstead, UK, HP2 4TZ
    +44 7513823507
  • Ranbaxy (UK) Ltd
    supplier

    Building 4, Chiswick Park, 566 Chiswick High Road, London, UK, W4 5YE
  • STADA UK - Thornton & Ross
    supplier

    Linthwaite, Huddersfield, UK, HD7 5JN
    +44 7979935409
  • Sandoz Ltd
    supplier

    Frimley Business Park, Frimley, Camberley, UK, GU16 7SR
  • Sheriff Court House
    reviewBody

    27 Chambers Street, Edinburgh, EH1 1LB
    +44 1312252525
  • Teva UK Ltd
    supplier

    Ridings Point, Whistler Drive, Glasshoughton, Castleford, UK, WF10 5HX
    +44 7780226334
  • Viatris UK Healthcare Ltd
    supplier

    Building 4, Trident Place, Mosquito Way, Hatfield, UKH23, AL10 9UL
    +44 7586494246
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published